Cat. No.: X24-08-YM343
Gap junction protein inhibitor, Gap 27, Purity ≥98%
Synonym: 198284-64-9; Gap-27; Gap27; (2S,3S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2S,3R)-2-[[(2S)-6-Amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoyl]amino]-4-carboxybutanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]-3-methylpentanoyl]amino]-3-methylpentanoic acid
- MDL: MFCD11045577
- CAS Number: 198284-64-9
- Compound CID: 9920128
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Properties
Description
Gap 27 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting gap junction protein.
Molecular Formula
C60H101N15O17
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Gap 27 is a cytoskeletal signaling inhibitor that can be used for its potential impact on diseases related to gap junction dysfunction, including cancer and cardiovascular disorders.
Related Products
-
Gap junction protein inhibitor, Tonabersat, Purity ≥98%
-
Gap junction protein inhibitor, Gap 26, Purity ≥98%
-
Gap junction protein inhibitor, GnRH associated peptide (GAP) (1-13), human, Purity ≥98%
-
Gap junction protein inhibitor, 10Panx, Purity ≥98%
-
Gap junction protein inhibitor, Scrambled 10Panx, Purity ≥98%
-
Gap junction protein inhibitor, GAP-134, Purity ≥98%
